{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/1b454f3a-002e-540e-82a0-3e5bcb0b5da9/652d5528d40c970012646735?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl","description":"<p>The drug naloxone, otherwise known as Narcan, is a critical tool in reversing fentanyl overdoses and reducing mortality. But now fentanyl is appearing on the streets adulterated with a drug called xylazine.&nbsp;</p><p><br></p><p>Justin Strickland, assistant professor at Johns Hopkins University School of Medicine, and Cassandra Gipson-Reichardt, associate professor in the department of pharmacology nutritional sciences at the University of Kentucky, are the coauthors of a new paper in the journal Neuropsychopharmacology about the importance of integrating public health and translational science to address the challenges of xylazine adulteration of fentanyl.&nbsp;</p><p><br></p><p>Read the <a href=\"https://www.nature.com/articles/s41386-023-01680-7\" rel=\"noopener noreferrer\" target=\"_blank\">full study here</a>: https://www.nature.com/articles/s41386-023-01680-7</p><p><br></p><p><br></p>","author_name":"Springer Nature"}